The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEurocell Regulatory News (ECEL)

Share Price Information for Eurocell (ECEL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 134.00
Bid: 132.00
Ask: 136.00
Change: -1.00 (-0.74%)
Spread: 4.00 (3.03%)
Open: 133.00
High: 135.50
Low: 133.00
Prev. Close: 135.00
ECEL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Launch of Share Buyback Programme

23 Jan 2024 07:00

RNS Number : 5275A
Eurocell plc
23 January 2024
 

23 January 2024

 

EUROCELL PLC

("Eurocell" or the "Group")

 

Launch of Share Buyback Programme

 

Eurocell plc, the market leading, vertically integrated UK manufacturer, recycler and distributor of innovative window, door and roofline PVC products, today announced that it intends to commence a new share buyback programme in respect of its ordinary shares of £0.001 each ("Ordinary Shares") up to a maximum consideration of £5 million from the date of this announcement (the "Buyback").

 

As referenced in today's Year End Trading Update, the Board is focused on enhancing shareholder returns and recognises the importance of our ordinary dividend. We will also periodically consider supplementary distributions, whilst always seeking to maintain a strong financial position. The Buyback will reduce the share capital of the Company and enhance earnings per share.

 

Details of the Share Buyback Programme

Eurocell has given irrevocable and non-discretionary instructions to Peel Hunt LLP ("Peel Hunt") in relation to the Buyback, which will commence on 23 January 2024. Peel Hunt will act as principal during the Buyback and will make trading decisions concerning the timing of the purchases of Ordinary Shares independently of the Company.

 

The maximum amount allocated to the Buyback is £5 million. Any market repurchase of Ordinary Shares will be announced no later than 7:30am on the business day following the calendar day on which the repurchase occurred. The first 642,000 Ordinary Shares that are repurchased will be held in treasury to satisfy employee share options over the next two years whilst any further Ordinary Shares that are repurchased will be cancelled.

 

Any purchases of Ordinary Shares contemplated by this announcement will be effected within certain pre-set parameters. These arrangements are in accordance with the authorities granted by the Company's shareholders at its annual general meeting held on 11 May 2023 to repurchase a maximum of 11,209,518 Ordinary Shares.

 

The maximum price payable for an Ordinary Share will be the lower of (a) 105% of the average of the middle market quotation for Ordinary Shares as derived from the Daily Official List of London Stock Exchange plc for the five business days before the date on which the purchase is made and (b) an amount equal to the higher of the last independent trade and highest current independent purchase bid.

 

Due to the limited liquidity in the Ordinary Shares, the Buyback may on any given trading day exceed 25 per cent but remain below 50 per cent of the average daily trading volume.

 

The arrangements relating to the maximum price and volume parameters are in accordance with Article 5(1) in the UK version of the Market Abuse Regulations (Regulation (EU) No 596/2014) as incorporated into UK domestic law by virtue of the European Union (Withdrawal) Act 2018. The limited liquidity of the Company allows for Market Abuse Regulations 1 Annex 1.1.9.3(b) Provision of the Buy-back and Stabilisation Regulation relating to buy-back programmes to warrant the exemptions specified.

 

Details of the authority granted at the 2023 AGM can be found on our website under: https://investors.eurocell.co.uk/investors/agm/

 

This announcement contains inside information for the purposes of the Market Abuse Regulation (EU) no. 596/2014 (including as it forms part of the laws of England and Wales by virtue of the European Union (Withdrawal) Act 2018) ('MAR').

 

 

Enquiries:

Eurocell plc

Darren Waters, Chief Executive Officer +44 (0) 1773 842 105

Michael Scott, Chief Financial Officer +44 (0) 1773 842 140

 

Teneo

Nick de Bunsen +44 (0) 7825 575 258

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSVLLFLZFLXBBK
Date   Source Headline
4th May 20217:00 amRNSTotal Voting Rights
26th Apr 20219:40 amRNSDirector/PDMR Shareholding
20th Apr 20217:00 amRNSBlock Listing Application
16th Apr 20211:10 pmRNSAnnual Financial Report
16th Mar 20211:39 pmRNSInvestor Presentation
12th Mar 20217:00 amRNSFinal Results
10th Mar 20217:00 amRNSBlock listing Interim Review
22nd Feb 202112:02 pmRNSNotice of Full Year Results Announcement
15th Jan 20217:00 amRNSYear End Trading Update – Strong Finish to 2020
12th Jan 20219:06 amRNSHolding(s) in Company
4th Jan 20217:00 amRNSTotal Voting Rights
1st Dec 20207:00 amRNSTotal Voting Rights
27th Nov 20207:00 amRNSDirector/PDMR Shareholding
19th Nov 20203:00 pmRNSDirector/PDMR Shareholding
19th Nov 20207:00 amRNSInvestor Presentation
17th Nov 20207:00 amRNSTrading Update – Improved Outlook
2nd Nov 20207:00 amRNSTotal Voting Rights
27th Oct 202011:23 amRNSHolding(s) in Company
15th Oct 202012:30 pmRNSDirector/PDMR Shareholding
1st Oct 20207:00 amRNSTotal Voting Rights
16th Sep 202012:20 pmRNSDirector/PDMR Shareholding
11th Sep 20207:00 amRNSDirector/PDMR Shareholding
7th Sep 202010:37 amRNSBlock listing Interim Review
4th Sep 20207:00 amRNSResults for the six months ended 30 June 2020
2nd Sep 20209:59 amRNSHolding(s) in Company
1st Sep 20207:00 amRNSTotal Voting Rights
27th Aug 20209:59 amRNSHolding(s) in Company
3rd Aug 20207:00 amRNSTotal Voting Rights
8th Jul 20207:00 amRNSCOVID-19 and Trading Update
1st Jul 20209:34 amRNSTotal Voting Rights
30th Jun 20204:53 pmRNSNotice of Results
4th Jun 202011:47 amRNSDirector Declaration
26th May 20209:37 amRNSBlock Listing Application
19th May 20208:46 amRNSResult of AGM - Correction
15th May 202011:34 amRNSResult of AGM
14th May 20207:00 amRNSAGM and COVID-19 Update
30th Apr 20205:09 pmRNSHolding(s) in Company
17th Apr 202012:55 pmRNSAnnual Financial Report
16th Apr 20205:02 pmRNSHolding(s) in Company
14th Apr 20202:52 pmRNSDirector/PDMR Shareholding
7th Apr 20202:14 pmRNSHolding(s) in Company
3rd Apr 202012:13 pmRNSHolding(s) in Company
1st Apr 20203:22 pmRNSDirector/PDMR Shareholding
1st Apr 20203:21 pmRNSResult of Placing
1st Apr 202011:43 amRNSPlacing of Ordinary Shares
24th Mar 20202:44 pmRNSCOVID-19 Update
13th Mar 20207:00 amRNSPreliminary Results for the year ended 31 Dec 2019
11th Mar 20203:59 pmRNSTransaction in Own Shares
10th Mar 20204:34 pmRNSBlock listing Interim Review
7th Jan 202012:29 pmRNSForm 8.3 - Eurocell PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.